LYMPHOMA . TRIALs: lymphoma - List Results - ClinicalTrials.gov

Found 3224 studies with search of: lymphoma
Hide studies that are not seeking new volunteers.


1 Recruiting Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
Conditions: Burkitt Lymphoma; Diffuse Large B-cell Lymphoma, c-MYC Positive
Interventions: Drug: rituximab; Drug: etoposide; Drug: cyclophosphamide; Drug: doxorubicin; Drug: vincristine; Drug: prednisone; Drug: filgrastim
Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma - Full Text View - ClinicalTrials.gov


2 Completed Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
Conditions: Non-Hodgkin's Lymphoma; Mantle Cell Lymphoma
Intervention: Drug: bendamustine hydrochloride
Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma - Full Text View - ClinicalTrials.gov


3 Terminated
Has Results Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma; Lymphoma
Intervention: Procedure: PET/CT Scanning
Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma - Full Text View - ClinicalTrials.gov


4 Active, not recruiting Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma
Conditions: Cutaneous T Cell Lymphoma; Peripheral T Cell Lymphoma
Intervention: Drug: Romidepsin
Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma - Full Text View - ClinicalTrials.gov


5 Recruiting Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
Conditions: Lymphoma; Nonneoplastic Condition
Interventions: Genetic: polymerase chain reaction; Other: laboratory biomarker analysis
Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma - Full Text View - ClinicalTrials.gov


6 Completed 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma
Condition: Lymphoma
Intervention: Drug: 17-AAG (Tanespimycin)
17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma - Full Text View - ClinicalTrials.gov

open here to see studies full-text: Found 3224 studies with search of: lymphoma
Search of: lymphoma - List Results - ClinicalTrials.gov